期刊文献+

骨髓增生异常综合征治疗进展

Progress on the treatment of myelodysplastic syndrome
下载PDF
导出
摘要 骨髓增生异常综合征(MDS)为生存及分化过程调节异常,影响原始造血祖细胞的增殖凋亡及分化,临床表现全血细胞减少,病程早期,以凋亡为主,晚期则增殖过程超过凋亡,继而使恶性克隆增殖向白血病衍变。本文重点介绍目前MDS新的治疗方法。 Myelodysplastic syndrome will impact the proliferation, apoptosis and differentiation of primitive hemopoietic progenitor cells, manifested clinically by pancytopenia. At early period, the main manifestation is apoptosis and at late stage, proliferation will exceed apoptosis and later the malignant clone hyperplasia will turn to leukemia. This paper mainly introduces the latest therapeutic strategies on myelodysplastic syndrome.
作者 王耀平
出处 《实用医院临床杂志》 2008年第5期18-20,共3页 Practical Journal of Clinical Medicine
关键词 骨髓增生异常综合征 输血 免疫抑制剂 免疫调控剂 表规遗传学 法尼基转移酶抑制剂 同种异基因造血干细胞移植 Myelodysplastic syndrome Transfusion Immunodepressant Immunoregulator Genetics Farnesyl transferase inhibitor Allogene hematopoietic stem cell transplant
  • 相关文献

参考文献10

  • 1Magda M,Alan F.List:Management of RBC-infusion Depemlenee[J].American Society of Education Program Blood.Hematology,2007,398-404.
  • 2Park S,Grabar S,Kelaidi C,et al.For the Groupe Framcophone des Myelodysplasies(GFM).Has treatmen! with EPO +/G-CSF an impact on progression to AML and surrvival in low/int-1-risk MDS? A comparison between Franch-EPO patients and the IMRAW database[J].Leuk Ras,2007,31 (2):s113.
  • 3Sakeras M,Maciejewski JP,Giagounidis A,et al.Cytopenias comtatc with response to lenalidomide in del 5 g MDS patients[J].Leukemia Research,2007,31 (4):s37-s38.
  • 4List A,Wuide K,Dewald G,et al.Cytngenetic Response to lenalidomide is associated with improved surrival in patients with chromosome 5 g deletion[J].Leu Res,2007,31 (5):s38.
  • 5Guillermo GM.Madifying the epigenome as a therapeutic strategy in mydodysplasia.Ameraean Society of Hematology Education program Blood[J].Hematology,2007,30 (7):405-411.
  • 6Peter A.Overview of cancer epigenetics,supplement to:seminars in hematology editors neals[J].Young photic beris,2005,42(3 suppl 2):s3-s8.
  • 7Soriano A,Chamolin R,Mccormick G,et al.Maintenance therapy with 5agacitidine after allogenneic stem all transplantation for acute myclogenous leukemia and high-risk myelodysplastie syndrome:a dese and schedule finding study.Blood,2005,108 (1):104.
  • 8Soriano A,Braitah F,Garcia G,et al.Combination of 5-agacitidine and valproic acid in advanced solid cancers:a phase I study[J].Proc Asco,2007,25 (8):3547.
  • 9Soriano AO,Yang H,Faderl S,et al.Safety and caincal activity of the combination of 5-agacitidine,valproic acid and all-trans rotinoic acid in acute mydaid[J].Blood,2007,110(7):2302-2308.
  • 10Richard L,Momparler A.Pharmacology of 5-aga-2'-deoxytidine (decifabink) I bid:s9-s16.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部